Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ribosomal mutations in Streptococcus pneumoniae clinical isolates.

Antimicrobial agents and chemotherapy - 1 Mar 2002

Pihlajamäki Marja, Kataja Janne, Seppälä Helena, Elliot John, Leinonen Maija, Huovinen Pentti, Jalava Jari

Abstract excerpt

Eleven clinical isolates of Streptococcus pneumoniae, isolated in Finland during 1996 to 2000, had an unusual macrolide resistance phenotype. They were resistant to macrolides and streptogramin B but susceptible, intermediate, or low-level resistant to lincosamides. No acquired macrolide resistance genes were detected from the strains. The isolates were found to have mutations in domain V of the 23S rRNA or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance
Share to Electrophoresis, Polyacrylamide Gel

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, Bacterial

Share to Pneumococcal Infections

Share to Ribosomes

Share to RNA, Ribosomal

Share to Serotyping

Share to Streptococcus pneumoniae

Source

Open in PubMed Open full text

Identifiers

PMID: 11850244
DOI: 10.1128/AAC.46.3.654-658.2002
PMCID: PMC127486

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ribosomal mutations in Streptococcus pneumoniae clinical isolates.PMID 11850244Read ↗

Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in Germany.Semantic proximity Read ↗

Epidemiology of macrolide and/or lincosamide resistant Streptococcus pneumoniae clinical isolates with ribosomal mutations.Semantic proximity Read ↗

Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations.Semantic proximity Read ↗

Prevalence and molecular genetics of macrolide resistance among Streptococcus pneumoniae isolates collected in Finland in 2002.Semantic proximity Read ↗

Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae.Semantic proximity Read ↗

Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae.Semantic proximity Read ↗

Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation.Semantic proximity Read ↗

Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China.Semantic proximity Read ↗

Mutations in 23S rRNA and Ribosomal Protein L4 Account for Resistance in Pneumococcal Strains Selected In Vitro by Macrolide PassageSemantic proximity Read ↗

Pneumococcal resistance to macrolides, lincosamides, ketolides, and streptogramin B agents: molecular mechanisms and resistance phenotypes.Semantic proximity Read ↗

Differences in the frequency of 23S rRNA gene mutations in Mycoplasma pneumoniae between children and adults with community-acquired pneumonia: clinical impact of mutations conferring macrolide resistance.Semantic proximity Read ↗

Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.